VX-950-TiDP24-C219: A Roll Over Trial for Patients in the Control Group of the C216 Study Who Received Telaprevir Placebo

Clinical trial NCT01054573 · COMPLETED

Trial details

NCT number: NCT01054573
Sponsor: Janssen Infectious Diseases BVBA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2010-04-01
Primary completion: 2012-03-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.